FLGT
Fulgent Genetics, Inc.
20.85
1 x 14.97
2 x 26.88
bid
ask
+
0.03
0.14%
10:15 AM
timesize
| Ytd | -20.63% | |
| 1y | 3.73% |
20.82
day range
21.18
13.46
52 week range
31.04
| Open | 21.00 | Prev Close | 20.82 | Low | 20.82 | High | 21.18 | Mkt Cap | 592.15M |
| Vol | 12.05K | Avg Vol | 480.76K | EPS | -2.40 | P/E | N/A | Forward P/E | -36.45 |
| Beta | 1.51 | Short Ratio | 2.87 | Inst. Own | 54.30% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-31 | 50-d Avg | 17.30 | 200-d Avg | 21.61 | 1yr Est | 27.67 |
| Income Statement | |||
| Total Revenue | 71.14M | ||
| Revenues (USD) | 71.14M | ||
| Cost of Revenue | 49.65M | ||
| Gross Profit | 21.49M | ||
| Operating Expenses | 56.11M | ||
| Research and Development Expense | 14.18M | ||
| Selling, General and Administrative Expense | 39.91M | ||
| Operating Income | -34.62M | ||
| Interest Expense | 17.00K | ||
| Income Tax Expense | -704.00K | ||
| Net Income | -24.83M | ||
| Net Income Common Stock | -24.83M | ||
| Net Income Common Stock (USD) | -24.83M | ||
| Consolidated Income | -25.27M | ||
| Net Income to Non-Controlling Interests | -448.00K | ||
| Earnings per Basic Share | -0.80 | ||
| Earnings per Basic Share (USD) | -0.80 | ||
| Earnings per Diluted Share | -0.80 | ||
| Earning Before Interest & Taxes (EBIT) | -25.51M | ||
| Earning Before Interest & Taxes (USD) | -25.51M | ||
| Weighted Average Shares | 30.88M | ||
| Weighted Average Shares Diluted | 30.88M | ||
| Balance Sheet | |||
| Cash and Equivalents | 23.40M | ||
| Cash and Equivalents (USD) | 23.40M | ||
| Investments | 581.19M | ||
| Investments Current | 252.90M | ||
| Investments Non-Current | 328.29M | ||
| Trade and Non-Trade Receivables | 69.28M | ||
| Current Assets | 479.04M | ||
| Property, Plant & Equipment Net | 116.34M | ||
| Total Assets | 1.16B | ||
| Debt Current | 482.00K | ||
| Total Debt | 482.00K | ||
| Current Liabilities | 90.13M | ||
| Total Liabilities | 112.22M | ||
| Accumulated Retained Earnings (Deficit) | 505.13M | ||
| Accumulated Other Comprehensive Income | 4.54M | ||
| Shareholders Equity | 1.05B | ||
| Shareholders Equity (USD) | 1.05B | ||
| Assets Non-Current | 677.33M | ||
| Total Debt (USD) | 482.00K | ||
| Deferred Revenue | 3.01M | ||
| Deposit Liabilities | 30.62M | ||
| Goodwill and Intangible Assets | 139.23M | ||
| Liabilities Non-Current | 22.08M | ||
| Trade and Non-Trade Payables | 21.13M | ||
| Tax Assets | 109.17M | ||
| Tax Liabilities | 12.71M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 6.35M | ||
| Net Cash Flow from Financing | -44.83M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -26.79M | ||
| Capital Expenditure | -5.19M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -55.57M | ||
| Issuance (Purchase) of Equity Shares | -40.07M | ||
| Issuance (Repayment) of Debt Securities | -564.00K | ||
| Net Cash Flow from Investing | 10.94M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 71.70M | ||
| Net Cash Flow from Operations | 7.10M | ||
| Effect of Exchange Rate Changes on Cash | 3.00K | ||
| Share Based Compensation | 9.89M | ||